Publication Name	World Journal of Gastroenterology
Manuscript ID	18173
Country	Japan

Received	2015-04-09 17:09
Peer-Review Started	2015-04-09 18:08
To Make the First Decision	2015-04-23 14:40
Return for Revision	2015-05-01 13:55
Revised	2015-06-12 00:49
Second Decision	2015-08-10 08:26
Accepted by Journal Editor-in-Chief	2015-08-11 15:53
Accepted by Executive Editor-in-Chief	2015-08-31 17:19
Articles in Press	2015-08-31 17:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-09 17:32
Publish the Manuscript Online	2015-09-28 11:42

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Topic Highlights
Article Title	Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Masatoshi Ishigami, Yasuhiro Ogura, Yoshiki Hirooka and Hidemi Goto
Funding Agency and Grant Number
Corresponding Author	Masatoshi Ishigami, MD, PhD, Department of Gastroenterology and Hepatology, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. masaishi@med.nagoya-u.ac.jp
Key Words	Liver transplantation; Hepatitis B virus; Prophylaxis; Hepatitis B immunoglobulin; Nucleos(t)ide analogue; Hepatitis B vaccine; Escape mutant
Core Tip	Liver transplantation for patients with hepatitis B virus (HBV)-related diseases is made remarkable progress since combination prophylaxis with nucleos(t)ide analogues and hepatitis B immunoglobulin was introduced. This combination prophylaxis is established as the gold standard in these days, however, the biggest problem is the high cost for longer use of these drugs. In this study, we show the history of preventive strategy against HBV after liver transplantation, and discuss what to and how to resolve the issues concerning posttransplant anti-HBV strategies with reported literature.
Publish Date	2015-09-28 11:42
Citation	Ishigami M, Ogura Y, Hirooka Y, Goto H. Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol 2015; 21(36): 10290-10298
URL	http://www.wjgnet.com/1007-9327/full/v21/i36/10290.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i36.10290

Full Article (PDF)	WJG-21-10290.pdf
Full Article (Word)	WJG-21-10290.doc
Manuscript File	18173-Review.doc
Answering Reviewers	18173-Answering reviewers.pdf
Audio Core Tip	18173-Audio core tip.wma
Conflict-of-Interest Disclosure Form	18173-Conflict-of-interest statement.pdf
Copyright License Agreement	18173-Copyright assignment.pdf
Peer-review Report	18173-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	18173-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	18173-Scientific misconduct check.pdf
Scientific Editor Work List	18173-Scientific editor work list.pdf